Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

Clinical trial NCT00982904 · COMPLETED

Trial details

NCT number: NCT00982904
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human African Trypanosomiasis

Start date: 2009-09-01
Primary completion: 2010-09-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.